Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Jul 22, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-20-000035.pdf 0001237899-20-000035.xls
Jul 15, 2020	CT ORDER	CT ORDER	View HTML 9999999997-20-004105.pdf
Jul 15, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-20-000087.pdf 0001708138-20-000087.xls
Jul 15, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-20-000088.pdf 0001708138-20-000088.xls
Jul 14, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-20-000031.pdf 0001237899-20-000031.xls
Jul 13, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-20-000030.pdf 0001237899-20-000030.xls
Jul 09, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-20-000084.pdf 0001708138-20-000084.xls
Jul 08, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-20-000029.pdf 0001237899-20-000029.xls
Jul 08, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-20-000028.pdf 0001237899-20-000028.xls
Jul 07, 2020	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-20-081559.pdf 0001104659-20-081559.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Data provided by Kaleidoscope.

Investors & Media